RPC
ABBV icon

Rossmore Private Capital’s AbbVie ABBV Stock Holding History

Rossmore Private Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$503K Hold
2,000
– – 0.04% 210
2026
Q1 		$435K Sell
2,000
-200
-9% -$44.4K 0.04% 215
2025
Q4 		$503K Buy
+2,200
New +$501K 0.04% 202

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Rossmore Private Capital's ABBV Position: Q2 2026 in Review

Rossmore Private Capital increased its AbbVie (ABBV) stake by 1.1% in Q2 2026, buying an estimated $113K and bringing the position to 46,722 shares worth $11.8M. The position accounts for 0.95% of the portfolio, ranked #26.

Rossmore Private Capital first reported a position in ABBV in Q4 2017 and has held it in 35 quarters since. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Rossmore Private Capital held 46,722 shares of AbbVie worth $11.8M as of Q2 2026.
  • Rossmore Private Capital bought 525 AbbVie shares in Q2 2026, an estimated $113K.
  • AbbVie made up 0.95% of Rossmore Private Capital's portfolio in Q2 2026, its #26 holding.
  • Rossmore Private Capital first reported a position in AbbVie in Q4 2017 and has held it in 35 quarters since.
  • 4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Rossmore Private Capital's 13F filing for Q2 2026, filed 31 Jul 2026.